Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis.

Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

Eligibility criteria

Qualifiers

Patients visiting the AMC outpatient clinic

MARK AF

INDICO AF

PREDICT AF

Disqualifiers

Age < 18

Unable or unwilling to comply with study procedures

Pregnancy or of childbearing potential without adequate contraception

NYHA class IV heart failure symptoms or left ventricular ejection fraction <35%.

Trial design

Treatments tested in this trial

  • Biobank for Left atrial appendage tissue
  • Biobank for Blood
  • Biobank for One or more of following fat patches: epicardial fat, subcutaneous fat, pericardial fat, visceral fat.

Treatment groups

1,000 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.